Quidel update point-of-care Sofia SARS Antigen Test for COVID-19 to include either nasal or nasopharyngeal swabs
On Aug. 19, 2020, Quidel announced that labeling for Quidel’s Emergency Use Authorization (EUA) for the Sofiaﾮ SARS…
BioNexus KC awarded grant to improve COVID-19 outcomes for patients with underlying health conditions
On Aug. 19, 2018, BioNexus KC announced it had been awarded a $42,900 grant from the Health Forward…
Bio-Techne and Leica Biosystems are acceleratied disease research with RNAscopeﾙ COVID-19 probes and the BOND RX
On Aug. 19, 2020, Bio-Techne in partnership with Leica Biosystems, announced the automation of RNAscopeﾙ COVID-19 probes on…
Johnson & Johnson acquired Momenta Pharmaceuticals for $65 billion
On Aug. 19, 2020, Johnson & Johnson announced an agreement to acquire Momenta Pharmaceuticals, a company that discovers…
UT Southwestern announced open enrollment for at-home COLCORONA clinical trial
On Aug. 19, 2020, researchers at UT Southwestern Medical Center and Texas Health Resources announced what is expected…
HKUMed researchers discovered that ORF8 and ORF3b are major targets of SARS-CoV-2 humoral immune response
On Aug. 18, 2020, researchers from HKU-Pasteur Research Pole at the School of Public Health, LKS Faculty of…
Regeneron and Roche collaborate to significantly increase global supply of REGN-COV2 investigational antibody cocktail for COVID-19
On Aug. 18, 2020, Regeneron and Roche announced that they had joined forces in the fight against COVID-19…
NIH delivered $43 million to support convalescent plasma clinical trial
On Aug. 18, 2020, the National Institutes of Health awarded Albert Einstein College of Medicine and Montefiore a…
Vanda Pharma’s interim analysis from ODYSSEY study showed tradipitant may accelerate clinical improvement in patients with COVID-19 pneumonia
On Aug. 18, 2020, Vanda Pharma reported that interim analysis showed tradipitant may accelerate clinical improvement in SARS-CoV-2…
FDA approved teatment for rare disease affecting optic nerves, spinal cord
On Aug. 17, 2020, the FDA approved Genentech’s Enspryng (satralizumab-mwge) for the treatment of neuromyelitis optica spectrum disorder…
XBiotech announced COVID-19 candidate therapy
On Aug. 17, 2020, XBiotech announced that it had identified True Human antibodies that could potentially be used…
FDA issued Emergency Use Authorization to Yale School of Public Health for SalivaDirect method of saliva sample processing
On Aug. 15, 2020, the FDA issued an emergency use authorization (EUA) to Yale School of Public Health…
Quick and affordable saliva-based COVID-19 test developed by Yale scientists received FDA Emergency Use Authorization
On Aug. 15, 2020, a saliva-based laboratory diagnostic test developed by researchers at the Yale School of Public…
Vaccine refusal and measles outbreaks increased in the US
On Aug. 14, 2020, in the U.S., despite high rates of coverage (>90%) at the national level for…
AstraZeneca concluded agreement with the EC for supply of up to 400 million doses of AZD1222 COVID-19 vaccine
On Aug. 14, 2020, AstraZeneca concluded an agreement with the European Commission (EC) to supply up to 400…
Mapping tool highlights NIH-funded small business successes
On Aug. 13, 2020, the NIH announced a new interactive mapping tool that showcases just some of the…
Philips launched Rapid Equipment Deployment Kit to COVID-19 response
On Aug. 13, 2020, Royal Philips introduced its Rapid Equipment Deployment Kit for ICU ramp-ups, allowing doctors, nurses,…
Dynavax announced grant to scale up CpG 1018 adjuvant capacity to support global COVID-19 response
On Aug. 13, 2020, Dynavax Technologies announced a grant from the Bill & Melinda Gates Foundation of $3.4…
Heat Biologics’ COVID-19 vaccine demonstrated robust T cell driven immune response to SARS-CoV-2 in preclinical studies
On Aug. 13, 2020, Heat Biologics reported preclinical data for Heat’s gp96-based COVID-19. The data, generated at the…
HHS announced collaboration with Aegis Sciences for high quality rapid COVID-19 RT-PCR testing
On Aug. 13, 2020, the U.S. Department of Health and Human Services (HHS) announced combined investments of $6.5…
Baxter obtained FDA Emergency Use Authorizations for HF20 set and ST set used in CRRT during Covid-19 pandemic
On Aug. 12, 2020, Baxter announced it had received Emergency Use Authorizations (EUAs) from the FDA for the…
FDA approved targeted treatment for rare Duchenne Muscular Dystrophy mutation
On Aug. 12, 2020, the FDA granted accelerated approval to NS Pharma’s Viltepso (viltolarsen) injection for the treatment…
Pfizer and BioNTech announced publication of peer-reviewed data from phase 1/2 study of mRNA-based vaccine candidate
On Aug. 12, 2020, Pfizer and BioNTech announced that preliminary, peer-reviewed data from their BNT162 mRNA-based vaccine development…
Hologic launched validated pooling protocol for COVID-19 testing
On Aug. 11, 2020, Hologic announced that it has validated use of its Aptimaﾮ and Panther Fusionﾮ molecular…
Bio-Techne announced new SARS-CoV-1/2 spike RBD LlaMABodyﾙ recombinant antibody that blocks viral entry
On Aug. 11, 2020, Bio-Techne announced the release of the SARS-CoV-1/2 Spike RBD LlaMABody Recombinant Antibody, which binds…
LabCorp to perform antibody test at no charge to accelerate COVID-19 blood plasma donation
On Aug. 11, 2020, LabCorpﾮ announced details of a no charge antibody testing program in response to federal…
Clinical trials of monoclonal antibodies to prevent COVID-19 began enrollment
On Aug. 10, 2020, two Phase 3, randomized, placebo-controlled, double-blind clinical trials testing whether experimental monoclonal antibodies (mAbs)…
25-year dolphin study revealed factors contributing to aging rates in long-lived mammals
On Aug. 10, 2020, Epitracker and the Translational Genomics Research Institute (TGen) announced the results from a groundbreaking,…
Vaxart announced IND filed for COVID-19 vaccine
On Aug. 10, 2020, Vaxart announced that its COVID-19 Investigational New Drug (IND) application has been filed with…
Cors Blood Registry by Generate Life Sciences partnered with Nantwest to develop COVID-19 treatment
On Aug. 10, 2020, CBRﾮ by Generate Life Sciences, the worldﾒs largest private newborn stem cell bank, and…